HIV Stigma Persists: 7 Months to Control a Drug-Resistant Strain
A drug-resistant HIV case reported from AIDS 2026 illustrates how treatment interruption and first-line liver toxicity complicate care — and why tolerability and resistance barriers still define antiretroviral differentiation. For biopharma, stigma-driven non-adherence is an upstream clinical risk that next-generation regimens must engineer around.